Eva Garland Consulting (EGC) is an Inc. 5000 fastest growing consulting firm that supports innovators in accessing billions of dollars in government grants and contracts.
Trending
Exclusive Seminar with Dr. Eva Garland — Register Now!
Join us for this exclusive event at our Irvine, CA office to discover how innovative companies can tap into the $100 billion of non-dilutive funding available each year. Gain expert insight from Dr. Eva Garland as she guides you through the complex U.S. funding landscape, covering hundreds of government programs as well as private foundation grants. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements.
EGC's June Newsletter
In this month’s newsletter, we are pleased to announce the launch of EGC Funding Alerts, a complimentary service that will provide real-time notifications of new funding opportunities. We are also proud to feature the achievements of our client, Sensorium Therapeutics, and to highlight a broad array of funding opportunities. Additionally, we look forward to catching up with many of you in-person this month at our events in Boston and Irvine!
Introducing EGC Funding Alerts: A Powerful New Tool to Access Non-Dilutive Funding
Eva Garland Consulting is thrilled to unveil EGC Funding Alerts, a new service designed to provide innovators, entrepreneurs, and researchers with real-time support in identifying the latest funding opportunities. Sign up now to start receiving updates tailored to your funding interests!
Recent News
February 13, 2025
New Funding Opportunities | Bill & Melinda Gates Foundation
January 16, 2025
2025 Winter Webinar Series
November 7, 2024
EGC Opens New Office in California
Eva Garland Consulting (EGC) is pleased to announce the opening of their newest office on the West Coast. Located in Irvine, California, this…
October 24, 2024
EGC Expands Headquarters with New Office Space in Raleigh to Support Growing Accounting Team
Eva Garland Consulting (EGC) is pleased to announce the expansion of its headquarters in Raleigh with a new office space in the Bank of America Tower…
Recent News
February 13, 2025
New Funding Opportunities | Bill & Melinda Gates Foundation
January 16, 2025
2025 Winter Webinar Series
November 7, 2024
EGC Opens New Office in California
Eva Garland Consulting (EGC) is pleased to announce the opening of their newest office on the West Coast. Located in Irvine, California, this…
October 24, 2024
EGC Expands Headquarters with New Office Space in Raleigh to Support Growing Accounting Team
Eva Garland Consulting (EGC) is pleased to announce the expansion of its headquarters in Raleigh with a new office space in the Bank of America Tower…
Client Highlights
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Boston Metal
Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Boston Metal
Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
Boston Metal
Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Our Clients Have Secured
$1,991,689,721
In Non-dilutive Funding
“I have had an excellent experience working with the team at Eva Garland consulting. Would highly recommend them!”
Richard Horowitz, Medical Director
“I have worked with Eva Garland over multiple grant applications and always had a stellar experience. Not only do they help as general writers but also perform great research and ask the hard questions required to make our applications really stand out.”
Grant Chapman, CEO
“I’ve worked with Eva Garland Consulting for nearly a decade, and throughout that time, they have consistently met, and often exceeded, all of my expectations. As a small startup operating in a highly technical and competitive space, we have relied on their guidance to help us navigate everything from complex SBIR/STTR compliance and accounting to strategic planning and funding advisement.”
Anthony Dellinger
“Our decision to work with Eva Garland was an excellent decision. They know what information the grant reviewers want to see, so were able to provide us with very helpful guidance that made our proposal far more persuasive.”
Brinton Baker, VP of Global Marketing
“I wanted to share our experience with the team so far. We are super impressed with their work and really enjoy working with EGC’s consultants! They are lovely and super talented.”
David Nason, CEO
“I would strongly recommend working with EGC for grant writing. They are very knowledgeable, professional, and easy to work with. I started working with them as a recipient of the NIH AAP program, but I have now continued seeking their help for all my grant writing, even if it is just to get a second pair of eyes on my submission package.”
Nordine Sebkhi, CEO
“I have had an excellent experience working with the team at Eva Garland consulting. Would highly recommend them!”
Richard Horowitz, Medical Director
“I have worked with Eva Garland over multiple grant applications and always had a stellar experience. Not only do they help as general writers but also perform great research and ask the hard questions required to make our applications really stand out.”